Margo Georgiadis

Margo Georgiadis is the Co-Founder and CEO of Montai Therapeutics, a biotechnology company focused on developing innovative treatments for chronic diseases.1 She is also a CEO-Partner at Flagship Pioneering, a firm that invests in and builds breakthrough bioplatform companies.2

Professional Background

Georgiadis has an extensive career in technology and business leadership:

• She previously served as President and CEO of Ancestry, where she led the company to become a global leader in family history and consumer genomics.23
• She spent nine years at Google as President of Americas and Vice President of Global Operations.23
• She has held executive roles at other companies, including CEO of Mattel, COO of Groupon, and EVP of US Card Services and CMO at Discover Financial Services.23

Current Roles

In addition to her position at Montai Therapeutics, Georgiadis:

• Serves as a CEO-Partner at Flagship Pioneering2
• Is a Managing Partner at Synetro Group3
• Holds board positions at several companies, including McDonald's Corporation, AppLovin, Ro, and Handshake35

Expertise and Focus

Georgiadis brings her expertise in technological innovation, artificial intelligence, and machine learning to advance biotech innovation.2 At Montai Therapeutics, she is working on:

• Developing an AI-driven small molecule platform to combat chronic diseases3
• Creating what the company calls "AnthromoleculeTM" medicines, which are based on scaffolds with a history of chronic human consumption4
• Marrying untapped chemistry with powerful biological pathways to make significant advancements in treating chronic diseases1

Recognition

Georgiadis has received numerous awards for her business and community leadership, including:

• Forbes "Excellence Award in Innovation"
• Chicago Innovation's "Visionary Award"
• Named to Crain's "Most Powerful Women in Business" list
• Included in Fortune's "50 Most Powerful Women in Business" list23

Margo Georgiadis holds a BA in Economics and an MBA from Harvard.2